<DOC>
	<DOCNO>NCT02417012</DOCNO>
	<brief_summary>This study evaluate effect lifestyle intervention maintenance glycemic control reduce glucose lower drug patient type 2 diabetes mellitus . The intervention group receive intensive lifestyle intervention include exercise diet lifestyle modification . The reference group receive diabetes educational advice . Both group pharmacological treatment regulate across study . The primary hypothesis lifestyle change sufficient maintain glycemic control decrease anti-diabetic medication sample patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>Lifestyle Glucose Lowering Medication T2DM</brief_title>
	<detailed_description>Adherence lifestyle modification include increased exercise healthy diet improves glycemic control patient type 2 diabetes mellitus . However , investigate combined effect lifestyle change maintenance glycemic control decrease usage anti-diabetic medication . The primary hypothesis lifestyle change equivalent maintain glycemic control ( Hba1c ) compare standard pharmacological treatment , The U-TURN trial also test effect one key secondary outcome ( glucose lower medication ) examine effect sleep quality , fatigue sleepiness , sleep pattern , cardio vascular disease risk factor , psychological outcome , blood pressure cholesterol lower medication . The participant ( N=120 ) randomize experimental group ( N=80 ) standard care group ( N=40 ) . Additionally , effect study evaluate 24 month post randomization .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Less three antidiabetic medication . Diabetes 2 duration max 10 year BMI &gt; 25 &lt; 40 kg/m2 , Accept medical regulation UTURN endocrinologists Accept purchase fitness club membership UTURN collaborator Hba1c &gt; 9 % ( 75 mmol/mol ) Insulin usage Presence one follow micro macrovascular complication T2DM ; a.Diabetic retinopathy ( except mild nonproliferative retinopathy early proliferative retinopathy ) b. Macroalbuminuria nephropathy c. Diabetic neuropathy ( except mild affected vibratory testing ( &lt; 50 Volt ) ) d. Arterial insufficiency e. Ischemic heart disease Steroid treatment ( inhalation ) three month medical examination TSH raised/below normal range Liver disease ( ALAT/ASAT thrice normal range ) Inability contraindication increase level physical activity ( Pedersen BK Saltin B ) Evidence anaemia Lung disease ( except mild asthma mild chronic obstructive pulmonary disease ) Heart disease Kidney disease ( creatinine 130 ÂµM macro albuminuria ) Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>lifestyle</keyword>
	<keyword>exercise</keyword>
	<keyword>physical activity</keyword>
	<keyword>diet</keyword>
	<keyword>glycemic control</keyword>
	<keyword>hba1c</keyword>
	<keyword>glucose lower drug</keyword>
</DOC>